3Rabe KF,Hurd S,Anzueto A. Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease:GOLD executive summary[J].American Journal of Respiratory and Critical Care Medicine,2007,(06):532-555.doi:10.1164/rccm.200703-456SO.
4Antoniu SA. Long-term bronchodilator inhaled therapy in COPD:the role of tiotropium bromidum[J].Rev Recent Clin Trials,2009,(02):89-98.
5Tashkin DP. Long-acting anticholinergic use in chronic obstructive pulmonary disease:efficacy and safety[J].Current Opinion in Pulmonary Medicine,2010,(02):97-105.
6Pera T,Zuidhof A,Valadas J. Tiotropium inhibits pulmonary inflammation and remodelling in a guinea pig model of COPD[J].European Respiratory Journal,2011,(04):789-796.
7Ohta S,Oda N,Yokoe T. Effect of tiotropium bromide on airway inflammation and remodelling in a mouse model of asthma[J].Clinical and Experimental Allergy,2010,(08):1266-1275.
8Tashkin DP,Celli B,Senn S. A 4-year trial of tiotropium in chronic obstructive pulmonary disease[J].New England Journal of Medicine,2008,(15):1543-1554.doi:10.1056/NEJMoa0805800.
9O'Donnell DE,Flüge T,Gerken F. Effects of tiotropium on lung hyperinflation,dyspnoea and exercise tolerance in COPD[J].European Respiratory Journal,2004,(06):832-840.
10Giamarellos-Bourboulis EJ. Macrolides beyond the conventional antimicrobials:a class of potent immunomodulators[J].International Journal of Antimicrobial Agents,2008,(01):12-20.doi:10.1016/j.ijantimicag.2007.08.001.
